Anti-RUNX1 + RUNX2 + RUNX3

Item number Size Datasheet Manual SDS Delivery time Quantity Price
ARG57484.100 100 µl - -

6 - 14 business days*

624.00€
 
Protein function: CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and... more
Product information "Anti-RUNX1 + RUNX2 + RUNX3"
Protein function: CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B- dependent transcriptional activation. Controls the anergy and suppressive function of regulatory T-cells (Treg) by associating with FOXP3. Activates the expression of IL2 and IFNG and down- regulates the expression of TNFRSF18, IL2RA and CTLA4, in conventional T-cells (PubMed:17377532). [The UniProt Consortium]
Keywords: Anti-AML1, Anti-RUNX1, Anti-CBF-alpha-2, Anti-PEA2-alpha B, Anti-PEBP2-alpha B, Anti-Oncogene AML-1, Anti-Acute myeloid leukemia 1 protein, Anti-Runt-related transcription factor 1, Anti-Core-binding factor subunit alpha-2
Supplier: Arigo Biolaboratories
Supplier-Nr: ARG57484

Properties

Application: WB, IHC (paraffin), ICC, IF, IP, FC
Antibody Type: Polyclonal
Conjugate: No
Host: Rabbit
Species reactivity: human, mouse, rat
Immunogen: Synthetic peptide derived from Human RUNX1 + RUNX2 + RUNX3
MW: 51 kD
Format: Affinity Purified

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-RUNX1 + RUNX2 + RUNX3"
Write a review
or to review a product.
Viewed